• OPEN AN ACCOUNT
Indian Indices
Nifty
26,053.90 117.70
(0.45%)
Sensex
84,997.13 368.97
( 0.44%)
Bank Nifty
58,385.25 171.15
( 0.29%)
Nifty IT
36,090.10 229.70
( 0.64%)
Global Indices
Nasdaq
47,736.03 170.44
(0.36%)
Dow Jones
6,915.96 19.80
(0.29%)
Hang Seng
51,290.81 1,071.63
(2.13%)
Nikkei 225
9,704.22 50.40
(0.52%)
Forex
USD-INR
88.12 0.31
(0.36%)
EUR-INR
102.54 0.45
(0.44%)
GBP-INR
117.47 0.63
(0.54%)
JPY-INR
0.58 0.00
(0.35%)

EQUITY - MARKET SCREENER

Novartis India Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500672
INE234A01025
317.91821
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NOVARTIND
20.74
2132.05
EPS(TTM)
Face Value()
Div & Yield %
41.63
5
2.89
 

As on: Oct 29, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
873.10 9.60 24114 20.74
Stock Price Details
Open Price() 879.95
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 915.00
Today's Low () 869.10
52-Week High () 1111
152-Week Low () 744.95
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.89
Eps 41.63
Book Value 317.91821
Market Cap (.Cr) 2,132.05
Face Value 5
Market Lot 1
AGM Date Jul
Book Closure Date Jul
ISIN No. INE234A01025


News
Novartis India standalone net profit rises 18.67% in the September 2025 quarter
Novartis India to conduct board meeting
Novartis India Ltd - Closure of Trading Window
Novartis India Ltd - Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Year And Quarter Ended September 30 2025.
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Novartis India standalone net profit rises 7.30% in the June 2025 quarter
Novartis India Ltd - Board Meeting Outcome for Intimation About The Outcome Of The Board Meeting Held On July 29 2025 Inter Alia For The Approval Of Unaudited Financial Statements For The Quarter Ending As On June 30 2025.
Novartis India Ltd - Unaudited Financial Results For The Quarter Ended As On June 30 2025.
Novartis India Ltd - Announcement under Regulation 30 (LODR)-Change in Management
Novartis India Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
More
Corporate Details
Incoporation Year   : 1947
Chairman : C Snook
Bussiness Group : MNC Associate
Registered Office
Novartis India Ltd
The Inspire BKC Part 601 & 701,
Bandra Kurla Complex Bandra(E),
Mumbai,
Maharashtra-400051
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-50243000
Fax:91-022-50243010
Fax:91-22-66317458
E-Mail : india.investors@novartis.com
URL : http://www.novartis.in


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE HC
  • BSE SmallCap
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi